Pfizer's bid to recapture Viagra China brand name falls limp , GBI

Release Date: 2009-08-20

The Supreme People's Court of China has rejected Pfizer's appeal to turn over a previous ruling regarding Pfizer's brand name rights to its erectile dysfunction (ED) drug Viagra, according to www.pharmtec.org.cn. This rejection marks the end of an 11-year conflict over the brand name.

The Beijing Municipal Higher People's Court ruled in April 2008 that Pfizer no longer had rights to the brand name, WeiGe, for Viagra. In 2006, Pfizer sued Guangzhou Welman Pharmaceutical and two other companies for trademark infringement for selling similar ED drugs with the Chinese characters `WeiGe'.

The Chinese characters for `WeiGe' translate to "Great Brother."
Type: NORMAL
Company: GBI
Country: 中国
Url: http://www.gbipharma.com/cpbheadline.asp?newsid=2010456
 
This website requires Flash Player 9 or later. If you can not view this site you probably need to update your system with this plug-in for your browser.